BioCryst Pharmaceuticals Inc. (BCRX) Financial Statements (2026 and earlier)

Company Profile

Business Address	4505 EMPEROR BOULEVARD DURHAM, NC 27703
State of Incorp.	DE
Fiscal Year End	December 31
Industry (SIC)	2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info	Complete Financial Analysis Financial Benchmarking

	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments	274,747	320,850	388,987	424,310	507,601	300,366
Cash and cash equivalent	89,736	104,713	110,643	304,767	504,389	272,127
Short-term investments	185,011	216,137	278,344	119,543	3,212	28,239
Restricted cash and investments	201	210	1,804	1,472	3,345	2,221
Receivables	106,818	79,069	2,296	8,268	1,980	8,243
Inventory, net of allowances, customer advances and progress billings	5,398	31,274	28,683	27,533	15,791	7,039
Inventory	5,398	31,274	28,683	27,533	15,791	7,039
Other undisclosed current assets	17,182	(9,435)	74,196	54,917	37,419	5,931
Total current assets:	404,346	421,968	495,966	516,500	566,136	323,800
Noncurrent Assets
Inventory, Noncurrent	23,990	23,187
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization	8,783	7,777	7,910	8,617	8,714	7,113
Long-term investments and receivables	61,164	20,323		18,077	6,829
Long-term investments	61,164	20,323		18,077	6,829
Restricted cash and investments
Other noncurrent assets	5,672	5,157	13,084	6,806	6,472	3,802
Other undisclosed noncurrent assets	10,203	12,008
Total noncurrent assets:	109,812	68,452	20,994	33,500	22,015	10,915
TOTAL ASSETS:	514,158	490,420	516,960	550,000	588,151	334,715
LIABILITIES AND EQUITY
Liabilities
Current Liabilities